VEGF application on rat skin flap survival

Journal of Investigative Surgery

Volumn 25, Issue 1, 2012, Pages 14-19

  Vourtsis, Spyridon A ^a   Spyriounis, Petros K ^b   Agrogiannis, George D ^c   Ionac, Mihai ^d   Papalois, Apostolos E ^e  

^a 401 Military Hospital of Athens   (Greece)

^b Center of Aesthetic and Plastic Surgery   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d WEST UNIVERSITY OF TIMISOARA   (Romania)

^e UNIVERSITY OF PATRAS   (Greece)

Author keywords

Angiogenesis; Distal necrosis; Flap survival; Growth factors; Neovascularization; VEGF

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOLOGY; IMAGE ANALYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN FLAP SURVIVAL; SURVIVAL RATE;

ANIMALS; MALE; NECROSIS; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, WISTAR; SURGICAL FLAPS; TISSUE SURVIVAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84856330836     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.3109/08941939.2011.593693     Document Type: Article

References (46)

1. Edington HE. Wound healing. In: Basic Science Review for Surgeons. Simmons RL, Steed DL, eds. Philadelphia, PA: WB Saunders; 1992:41-55.
2. Attisano L, Wrana JL, Lopez-Casillas F, et al. TGF-beta receptors and actions: minireview. Biochem Biophys Acta. 1994;1222:71-80.
3. Deuel TF, Kawahara RS, Mustoe TA, et al. Growth factors and wound healing: platelet-derived growth factor as a model cytokine. Ann Rev Med. 1991;42:567-574.
4. Folkman J, Klagsburn M. Angiogenic factors. Science 1987;235:442-447. (Pubitemid 17009577)
5. Knighton DR, Ciresi KF, Fiegel V, et al. Classifcations and treatment of chronic nonhealing wounds. Ann Surg. 1986;104:322-330.
6. Lynch SE, Nixon JC, Colvin RB, et al. Role of platelet-derived growth factor in wound healing: synergistic effects with growth factors. Proc Natl Acad Sci USA. 1987;84:7696-7697.
7. Houck KA, Leung DW, Rowland AM, et al. Dual regulation of vascular endothelial growth factor bioavailabil-ity by genetic and proteolytic mechanisms. J Biol Chem. 1992;267:26031-26037. (Pubitemid 23014012)
8. Park JE, Keller GA, Ferrara N. The vascular endothe-lial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioac-tivity of extracellular matrix-bound VEGF. Mol Biol Cell. 1993;4:1317-1326. (Pubitemid 24045761)
9. Flamme I, von Reutern M, Drexler HC, et al. Overexpres-sion of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation. Dev Biol. 1995;171:399-414.
10. Hippenstiel S, Krull M, Ikemann A, et al. VEGF induces hy-perpermeability by a direct action on endothelial cells. Am J Physiol. 1998;274:L678-L684.
11. Yang R, Thomas GR, Bunting S, et al. Effects of vascular en-dothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol. 1996;27:838-844. (Pubitemid 26000416)
12. Steed DL. The role of growth factors in wound healing. Surg Clin North Am. 1997;77:575-586. (Pubitemid 27256035)
13. Khouri RK, Brown DM, Leal-Khouri SM, et al. The effect of basic fbroblast growth factor on the neovascularization process: skin fap survival and staged fap transfers. Br J Plast Surg. 1991;44:585-588.
14. Kryger Z, Zhang F, Dogan T, et al. The effects of VEGF on survival of a random fap in the rat: examination of various routes of administration. Br J Plast Surg. 2000;53:234-239. (Pubitemid 30216404)
15. Lu WW, Ip WY, Jing WM, et al. Biomechanical properties of thin skin fap after basic fbroblast growth factor (bFGF) administration. Br J Plast Surg. 2000;53:225-229. (Pubitemid 30216402)
16. Nall AV, Brownlee RE, Colvin CP, et al. Transforming growth factor beta 1 improves wound healing and random fap survival in normal and irradiated rats. Arch Otolaryngol Head Neck Surg. 1996;122:171-177. (Pubitemid 26056775)
17. Ishiguro N, Yabe Y, Shimizu T, et al. Basic fbroblast growth factor has a benefcial effect on the viability of random skin faps in rats. Ann Plast Surg. 1994;32:356-360. (Pubitemid 24117938)
18. Rashid MA, Akita S, Razzaque MS, et al. Coadministra-tion of basic fbroblast growth factor and sucrose octasul-fate (sucralfate) facilitates the rat dorsal fap survival and viability. Plast Reconstr Surg. 1999;103:941-948. (Pubitemid 29109083)
19. Im MJ, Kim YS, Edwards RJ, et al. The effect of bovine basic fbroblast growth factor on skin fap survival in rats. Ann Plast Surg. 1992;28:242-245.
20. Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585-601.
21. McGrath MH. Peptide growth factors and wound healing. Clin Plast Surg. 1990;17:421-432. (Pubitemid 20321234)
22. Rothe MJ, Falanga V. Growth factors and wound healing. Clin Dermatol. 1992;9:553-559.
23. 3 integrin, osteo-pontin, and thrombin. Am J Pathol. 1996;149:293.
24. Papapetropoulos A, Garcia-Cardena G, Madri JA, et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human en-dothelial cells. J Clin Invest. 1997;100:3131-3139. (Pubitemid 28022851)
25. Alon T, Hemo I, Itin A, et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1995;1:1024-1028.
26. Arkonac BM, Foster LC, Sibinga NE, et al. Vascular en-dothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothe-lial cells. J Biol Chem. 1998;273(8):4400-4405. (Pubitemid 28103177)
27. Dahlfors G, Arnqvist, HJ. Vascular endothelial growth factor and transforming growth factor-1 regulate the expression of insulin-like growth factor-binding protein-3,-4, and-5 in large vessel endothelial cells. Endocrinology 2000;141(6):2062-2067. (Pubitemid 32274357)
28. Suzuma K, Naruse K, Suzuma I, et al. Vascular endothe-lial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J Biol Chem. 2000;275(52):40725-40731. (Pubitemid 32054890)
29. Zhang F, Oswald T, Lin S, et al. Vascular endothelial growth factor (VEGF) expression and the effect of exogenous VEGF on survival of a random fap in the rat. Br J Plast Surg. 2003:56(7):653-659. (Pubitemid 37304477)
30. Yan H, Zhang F, Kochevar AJ, et al. The effect of post-conditioning on the muscle fap survival after ischemia-reperfusion injury in rats. J Invest Surg. 2010;23(5): 249-256.
31. Machens HG, Salehi JS, Weich H, et al. Angiogenic effects of injected VEGF165 and sVEGFR-1 (sFLT-1) in a rat fap model. J Surg Res. 2003;111:136-142. (Pubitemid 36808709)
32. Krum JM, Mani N, Rosenstein JM. Angiogenic and astroglial response to vascular endothelial growth factor administration in adult rat brain. Neuroscience 2002;110:589-604. (Pubitemid 34270531)
33. Pettersson A, Nagy JA, Brown CS, et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular growth factor. Lab Invest. 2000;80:99-115. (Pubitemid 30067385)
34. Angel MF, Ramasastry SS, Swartz WM, et al. The critical relationship between free radicals and degrees of ischemia: evidence for tissue intolerance of marginal perfusion. Plast Reconstr Surg. 1988;81:233-239. (Pubitemid 18054327)
35. Kerrigan CL, Daniel RK. Critical ischemic time and the failing skin fap. Plast Reconstr Surg. 1982;69:986-989. (Pubitemid 12074683)
36. May JW, Chait LA, O'Brien BM, et al. The no-refow phenomenon in experimental free faps. Plast Reconstr Surg. 1978;61:256-267. (Pubitemid 8277578)
37. Milton SH. Experimental studies on island faps: ischemia and delay. Plast Reconstr Surg. 1972;49:444-447.
38. Selye H. Ischemic necrosis: prevention by stress. Science 1967;156:1262-1263.
39. Willms-Kretschmer K, Majno G. Ischemia of the skin: electron microscopic study of vascular injury. Am J Pathol. 1969;54:327-353.
40. Phillips L, Toledo AH, Lopez-Neblina F, et al. Nitric oxide mechanism of protection in ischemia and reperfusion injury. J Invest Surg. 2009;22(1):46-55.
41. Zachary I. Vascular endothelial growth factor. Int J Biochem Cell Biol. 1998;30:1169-1174. (Pubitemid 28515661)
42. Hashimoto E, Ogita T, Nakaoka T, et al. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol. 1994;267: H1948-H1954.
43. Witte M, Barbul A. Role of nitric oxide in wound repair. Am J Surg. 2002;183:406.
44. von Marschall Z, Cramer T, Höcker M, et al. Dual mechanism of vascular endothelial growth factor upregula-tion by hypoxia in human hepatocellular carcinoma. Gut 2001;48(1):87-96. (Pubitemid 32042647)
45. Stein I, Neeman M, Shweiki D, et al. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hy-poglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol. 1995;15:5363-5368.
46. Khan A, Ashrafpour H, Huang N, et al. Acute local subcutaneous VEGF165 injection for augmentation of skin fap viability: effcacy and mechanism. Am J Physiol Regul Integr Comp Physiol. 2004;287(5):R1219-R1229. (Pubitemid 39391069)